Add BrightSurf on Google Email

New study puts gut microbiome at the center of Parkinson’s disease pathogenesis

A recent study published in Nature Communications has found a significant imbalance in the gut microbiome of individuals with Parkinson's disease. The researchers discovered that over 30% of micro-organisms and bacterial genes tested had altered abundances, indicating a widespread imbalance in the microbiome.

SourceUniversity of Alabama at Birmingham·JournalNature Communications·TypeData/statistical analysis·DateJan 10, 2023

Deep brain stimulation for Parkinson's disease: new algorithm for the adjustment of stimulation settings developed

A new algorithm developed by researchers at Charité improves motor symptoms comparable to standard of care treatment, increasing efficiency in deep brain stimulation for Parkinson's disease. The study suggests a promising result for imaging-based algorithms to simplify clinical practice and improve therapeutic outcomes.

SourceCharité - Universitätsmedizin Berlin·JournalThe Lancet Digital Health·DateDec 21, 2022

Study traces shared and unique cellular hallmarks found in 6 neurodegenerative diseases

A recent study has identified common and unique cellular processes in six neurodegenerative diseases, providing new insights into the underlying causes of these conditions. The research used machine learning analysis to compare RNA markers in whole blood samples from patients with distinct diseases, revealing eight shared themes across...

SourceArizona State University·JournalAlzheimer s & Dementia·TypeData/statistical analysis·DateDec 21, 2022

New study shows the incidence of Parkinson’s disease in the U.S. is 50% higher than previous estimates

A new study found the annual incidence of Parkinson’s disease in the U.S. to be nearly 90,000 cases per year, a 50% increase from previous estimates of 60,000 diagnoses annually. The increased incidence is attributed to an aging population and highlights the need for more research and better treatments.

SourceParkinson's Foundation·Journalnpj Parkinson s Disease·TypeMeta-analysis·DateDec 15, 2022

Researchers map deep brain stimulation target for Alzheimer's disease

A recent study suggests that stimulating the intersection of two particular brain networks correlated with better patient outcomes than stimulating nearby sites for patients with Alzheimer's disease. Cognitive improvement was associated with DBS to the direct interface between the fornix and bed nucleus of the stria terminalis.

SourceBrigham and Women's Hospital·JournalNature Communications·TypeRandomized controlled/clinical trial·DateDec 14, 2022

New blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms emerge, study shows

A new laboratory test can measure levels of amyloid beta oligomers in blood samples, detecting toxic proteins up to years before cognitive impairment. The test, SOBA, has shown promising results in identifying individuals at risk or incubating Alzheimer's disease.

SourceUniversity of Washington·JournalProceedings of the National Academy of Sciences·TypeRandomized controlled/clinical trial·DateDec 5, 2022

Growing evidence for the role of the immune system in Parkinson’s disease

The latest research evidence suggests that inflammation may play a causative role in Parkinson's disease. Multiple independent studies have provided evidence of the involvement of central and peripheral immune and inflammatory processes in PD, with increasing evidence suggesting an association with autoimmune conditions.

SourceIOS Press·JournalJournal of Parkinson’s Disease·TypeSystematic review·DateDec 1, 2022

Protein mutation that causes Parkinson’s may prevent another neurodegenerative disease

Researchers have discovered that a specific mutation in the misfolding protein causing Parkinson's disease can also protect against multiple system atrophy (MSA), another fatal neurodegenerative disorder. The findings provide a promising lead for developing targeted treatments using personalized medicine approaches.

SourceUniversity of Massachusetts Amherst·JournalPLOS Pathogens·TypeObservational study·DateDec 1, 2022

New Carnegie Mellon University research investigates how the brain processes language

A recent study published in Nature Computational Science reveals that specific regions of the brain process both individual and combined words, while others focus solely on individual words. The research could contribute to the development of wearable neurotechnology devices that can decode language directly from brain activity.

SourceCarnegie Mellon University·JournalNature Computational Science·DateNov 29, 2022

Protein shapes indicate Parkinson’s disease

Researchers at ETH Zurich have identified 76 proteins that could serve as biomarkers for Parkinson's disease, with their molecular structures differing between healthy and diseased individuals. The study uses a unique method to analyze protein shapes in cerebrospinal fluid, providing a promising new approach for diagnosis and potential...

SourceETH Zurich·JournalNature Structural & Molecular Biology·DateNov 25, 2022

Researchers identify a molecular mechanism associated with juvenile Parkinson’s

A team of researchers has deciphered the molecular mechanism linked to juvenile Parkinson's disease, a genetic mutation affecting the adenosine type 1 receptor gene. The mutation alters the interaction between adenosine receptors, leading to increased neuronal circuit excitability in the brain region striatum.

SourceUniversity of Barcelona·JournalBiomedicine & Pharmacotherapy·TypeExperimental study·DateNov 8, 2022

University of Colorado study investigates aggression toward caregivers in Parkinson’s disease patients

A University of Colorado study reveals aggressive behavior towards caregivers is a significant issue in Parkinson's disease, with factors including grief, loss of motor symptoms, and cognitive fluctuations identified as contributing to the problem. The research also highlights the impact on caregivers' mental health and relationships.

SourceUniversity of Colorado Anschutz Medical Campus·JournalMovement Disorders·DateNov 7, 2022

Even fruit flies count

A new computational model based on fruit fly brain data may help explain how humans process memories and experiences. The model suggests that living organisms, including humans, use a similar '1-2-3-many' count sketch to track encounters with familiar sights and smells.

SourceCold Spring Harbor Laboratory·JournalNature Communications·DateOct 31, 2022

Zinc enhances albumin’s protective role against Parkinson's disease

Researchers have discovered that zinc ions tune the ability of human serum albumin to prevent α-synuclein aggregation, a process linked to Parkinson's disease. Zinc binding alters HSA's chaperone function, blunting fibril formation and slowing down protein deposition that can lead to neurodegeneration.

SourceKing Abdullah University of Science & Technology (KAUST)·JournalInternational Journal of Biological Macromolecules·DateOct 16, 2022

Team uses digital cameras, machine learning to predict neurological disease

A team of researchers used digital cameras and machine learning algorithms to develop a system that can predict gait dysfunctions in people with multiple sclerosis and Parkinson's disease. The study revealed that several algorithms were over 75% accurate at detecting differences between those with the conditions and those without.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalIEEE Journal of Biomedical and Health Informatics·TypeComputational simulation/modeling·DateOct 11, 2022

Voice screening App delivers rapid results for Parkinson’s and severe COVID

A new screening test App can produce accurate results using just people's voice recordings, improving the management of Parkinson's disease and severe COVID-19. The smartphone App takes just 10 seconds to reveal whether a person may have Parkinson’s disease and should be referred to a neurologist.

SourceRMIT University·JournalIEEE Journal of Translational Engineering in Health and Medicine·TypeObservational study·DateOct 5, 2022

Study: Decreased proteins, not amyloid plaques, tied to Alzheimer’s disease

Researchers from the University of Cincinnati found that low levels of soluble amyloid-beta protein in the brain, rather than its buildup into plaques, are associated with cognitive decline and Alzheimer's disease. Patients with high levels of soluble amyloid-beta showed improved cognitive outcomes, contradicting previous theories.

SourceUniversity of Cincinnati·JournalJournal of Alzheimer’s Disease·TypeObservational study·DateOct 4, 2022

National Institutes of Health Awards Cleveland Clinic $10.7 Million to expand national consortium studying Dementia with Lewy Bodies

The National Institutes of Health has awarded a $10.7 million grant to Cleveland Clinic to expand a national research consortium focused on improving diagnosis and treatments for Dementia with Lewy Bodies. The consortium, which includes multiple clinical sites, aims to identify biomarkers for disease and develop new therapies.

Improving hospital stays and outcomes for older patients with dementia through AI

Researchers developed a machine learning model to quickly recognize predictive risk factors and their importance for undesirable hospitalization outcomes. The model achieved an accuracy of 95.6% and identified modifiable risk factors that can be mitigated through clinical interventions.

SourceHouston Methodist·JournalAlzheimer s & Dementia Translational Research & Clinical Interventions·TypeData/statistical analysis·DateSep 29, 2022

COVID-19 infections increase risk of long-term brain problems

New research shows that COVID-19 infections can lead to a range of neurological complications in the first year after infection, including strokes, cognitive decline, depression, anxiety, and migraine headaches. The study analyzed over 14 million medical records and found that COVID-19 survivors were at increased risk of developing the...

SourceWashington University in St. Louis·JournalNature Medicine·TypeData/statistical analysis·DateSep 22, 2022

Aged neurons generated directly from skin more accurately model Parkinson’s disease

Researchers have successfully created dopaminergic neurons directly from the skin of patients with Parkinson's disease, preserving aged characteristics and cellular defects. This breakthrough allows for modeling PD-related neuronal defects in a larger cohort of patients, aiming to identify disease causes and potential therapies.

SourceInternational Society for Stem Cell Research·JournalStem Cell Reports·DateSep 22, 2022

Repeated infections associated with increased risk of some neurodegenerative diseases

A new study published in PLOS Medicine found that people with hospital-treated infections in early- and mid-life had a higher risk of developing Alzheimer's disease (AD) and Parkinson's disease (PD). The research analyzed data on over 291,000 cases and matched controls to identify the association between infections and neurodegenerativ...

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateSep 15, 2022

Moderate drinking linked to brain changes and cognitive decline

A study of almost 21,000 people found that moderate drinking is associated with higher iron levels in the brain and poorer cognitive function. Iron accumulation is a potential mechanism for alcohol-related cognitive decline, which can lead to Alzheimer's and Parkinson's diseases.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateJul 14, 2022